Pharmaceutical Drug Delivery System Market
Global Pharmaceutical Drug Delivery System Market Size, Share & Trends Analysis Report by Route of Administration (Injectable Drug Delivery, Topical Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, and Others), by Application (Infectious Diseases, Cancer, Cardiovascular Diseases (CVDs), Diabetes, Nervous System Disorders, Respiratory Diseases, and Others), by End-User (Hospitals and Clinics, Ambulatory Surgery Centers (ASCs), Homecare, and Diagnostic Centers) and Forecasts, 2019 – 2025 Update Available - Forecast 2024-2030
Drug delivery is a process of administering a pharmaceutical compound for achieving a therapeutic effect in humans or animals. The global pharmaceutical drug delivery system market size is expected to expand at a significant rate during the forecast period. One of the major factors contributing to the growth of the market includes increasing prevalence of chronic diseases such as cancer, CVDs, respiratory diseases, and others. The rising burden of such chronic diseases is encouraging the pharmaceutical companies to invest in R&D for the development of novel technologies for drug delivery, which in turn is propelling the growth of the market. In addition, growth in the biologics market further gives a boost to the growth of the global market.
Surging Prevalence of Chronic Diseases is Driving the Market Growth
Surging prevalence of chronic diseases such as cancer, CVDs, and diabetes, among others are expected to drive the demand for pharmaceutical drugs, which in turns, augments the growth of pharmaceutical drug delivery system market. Increasing prevalence of CVDs is estimated to be one of the major factors that are driving the growth of the market across the globe. As per the World Health Organization (WHO), CVDs are estimated as one of the major causes of mortality across the globe, accounting for more than 17.3 million mortality per year. Further, the number of mortalities by CVDs is estimated to reach 23.6 million by 2030. CVDs account for 31% mortalities globally, of which 80% occur in low and middle-income countries. According to the data from the American Heart Society, in 2017, CVDs are the cause of around 800,000 mortalities in the US. Moreover, heart diseases are the leading cause of mortality across the globe and the US, and about 370,000 Americans lose their lives every year. In addition, the prevalence of cancer is also expected to support the significant growth of the market across the globe. According to the WHO, the global cancer burden was estimated to have risen to 18.1 million new cases and 9.6 million mortalities in 2018. Further, the aforementioned organization estimates that 1 in 5 men and 1 in 6 women, across the globe, develop cancer during their lifetime. Moreover, the disease has a mortality rate of nearly one in 8 men and one in 11 women.
Segmental Outlook
The global pharmaceutical drug delivery system market is segmented on the basis of route of administration, application, and end-user. On the basis of route of administration, the report analyzes injectable drug delivery, topical drug delivery, pulmonary drug delivery, nasal drug delivery, and others. On the basis of application, the market is segregated into infectious diseases, cancer, CVDs, diabetes, nervous system disorders, respiratory diseases, and others. Whereas, on the basis of end-user, the market is classified into hospitals & clinics, ASCs, homecare, and diagnostic clinics. Hospitals and clinics end-user segment are expected to dominate the overall market in 2018. This is due to many inpatient and outpatient visits to hospitals. Further, a significant requirement of a large volume of drugs along with their respective devices to fulfill the demand of the large patient pool is also augmenting the growth of the hospitals and clinics segment.
Global Pharmaceutical Drug Delivery System Market Share by End-User, 2018 (%)
Respiratory Diseases Application Segment to Contribute Significantly Over the Forecast Period
Pharmaceutical drug delivery system for respiratory diseases held a significant share in 2018. The growth of this segment is expected to be driven by increasing prevalence of chronic obstructive pulmonary disease (COPD) coupled with the increasing number of smokers across the globe. The significant prevalence of COPD has been recorded across the globe. According to WHO, there were 251 million COPD cases reported across the globe in 2016. Moreover, it was estimated that 3.17 million mortalities were caused due to COPD in 2015, which is 5% of all the mortalities occurred in 2016, globally. Moreover, the prevalence of COPD is further expected to increase in near future owing to surging geriatric population pool and smoking prevalence across the globe. These facts and figures reflect the need for pharmaceutical drugs for the treatment of COPD and other respiratory disorders. Thereby, augmenting the demand for various drug delivery systems.
Regional Outlook
The report analyzes the global pharmaceutical drug delivery system market on the basis of region into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to dominate the market in 2018 followed by Europe and Asia-Pacific. Major economies contributing to the market growth of Europe include UK, Germany, France, Italy, Spain, and others. Asia-Pacific is expected to register the fastest growth over the forecast period. The growth of the region is due to the surging prevalence of chronic disorders coupled with increasing geriatric population and rapidly evolving healthcare industry across emerging economies of Asia-Pacific such as India, China, Indonesia, and South Korea.
Global Pharmaceutical Drug Delivery System Market Growth, 2019-2025
North America led the market in 2018
North America is expected to dominate the global pharmaceutical drug delivery system market in 2018. The dominant share of the region is attributed to well-developed healthcare infrastructure, significant growth in biologics in the pharmaceutical market and presence of key players across the regions such as 3M Co., Baxter International, Inc., and Boston Scientific Corp., among others. Moreover, increasing prevalence of chronic disorders such as cancer, CVDs, diabetes, and COPD is further augmenting the growth of the market in North America.
Market Players Outlook
The global pharmaceutical drug delivery system market consists of several market players that are manufacturing and marketing various pharmaceutical drug delivery systems across the globe. Boehringer Ingelheim International GmbH is one of the major players operating significantly in the market. The company is dealing in the manufacturing and marketing of medicines for the treatment of CVDs, oncology, metabolic, respiratory, and immunology diseases. The company manufactures Spiriva, an inhaler used for the treatment of COPD and asthma. In 2017, Spiriva has added nearly $3.3 billion in the company’s overall sales. Additionally, GlaxoSmithKline PLC, AstraZeneca PLC, Bayer AG, F. Hoffmann-La Roche Ltd., and others are also expected to contribute significantly to the market growth.
Recent Developments
- In 2018, Johnson & Johnson signed an agreement with the Oklahoma Health Care Authority (OHCA) to improve care among patients with schizophrenia and also to cut down the expenses for medical services. Moreover, the agreement is focused on enabling the use of INVEGA SUSTENNA and INVEGA TRINZA in the treatment of adults suffering from schizophrenia.
- In 2018, Johnson & Johnson collaborated with the Jenner Institute at the University of Oxford to develop and manufacture a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
- In 2018, Novartis signed an agreement with Gan & Lee Pharmaceutical, Ltd. to commercialize and supply biosimilar versions of insulins (glargine, lispro, and aspart), used in patients with type 1 and type 2 diabetes.
The Report Covers
- Market value data analysis of 2018 and forecast to 2025.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global pharmaceutical drug delivery system market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. GlaxoSmithKline PLC
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. Swot Analysis
3.3.1.4. Recent Developments
3.3.2. AstraZeneca PLC
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. Swot Analysis
3.3.2.4. Recent Developments
3.3.3. Boehringer Ingelheim International GmbH
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. Swot Analysis
3.3.3.4. Recent Developments
3.3.4. Bayer AG
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. Swot Analysis
3.3.4.4. Recent Developments
3.3.5. F. Hoffmann-La Roche Ltd.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. Swot Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Pharmaceutical Drug Delivery System Market by Route of Administration
5.1.1. Injectable Drug Delivery
5.1.2. Topical Drug Delivery
5.1.3. Pulmonary Drug Delivery
5.1.4. Nasal Drug Delivery
5.1.5. Others (Ocular Drug Delivery)
5.2. Global Pharmaceutical Drug Delivery System Market by Application
5.2.1. Infectious Diseases
5.2.2. Cancer
5.2.3. Cardiovascular Diseases (CVDs)
5.2.4. Diabetes
5.2.5. Nervous System Disorders
5.2.6. Respiratory Diseases
5.2.7. Others (Autoimmune Disorders)
5.3. Global Pharmaceutical Drug Delivery System Market by End-User
5.3.1. Hospitals and Clinics
5.3.2. Ambulatory Surgery Centers (ASCs)
5.3.3. Homecare
5.3.4. Diagnostic Centers
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. 3B Medical Inc.
7.2. 3M Co.
7.3. Acorda Therapeutics Inc.
7.4. Amgen Inc.
7.5. Antares Pharma, Inc.
7.6. AstraZeneca PLC
7.7. Baxter International, Inc.
7.8. Bayer AG
7.9. Becton, Dickinson and Co.
7.10. BMC Medical Co. Ltd.
7.11. Boehringer Ingelheim International GmbH
7.12. Boston Scientific Corp.
7.13. F. Hoffmann-La Roche Ltd.
7.14. GlaxoSmithKline PLC
7.15. Invacare Corp.
7.16. Johnson & Johnson
7.17. Koninklijke Philips N.V.
7.18. Medtronic PLC
7.19. Merck KGaA
7.20. Mylan N.V.
7.21. Novartis AG
7.22. Omron Healthcare Inc.
7.23. Pfizer, Inc.
7.24. PMD Device Solutions Ltd.
7.25. ProMed Pharma LLC
7.26. ResMed Inc.
7.27. Sanofi SA
7.28. Teicos Pharma, Ltd.
1. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
2. GLOBAL INJECTABLE PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL TOPICAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL PULMONARY PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
5. GLOBAL NASAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
6. GLOBAL OTHER ROUTES FOR PHARMACEUTICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
7. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
8. GLOBAL PHARMACEUTICAL DRUG DELIVERY FOR INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
9. GLOBAL PHARMACEUTICAL DRUG DELIVERY FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
10. GLOBAL PHARMACEUTICAL DRUG DELIVERY FOR CVD MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
11. GLOBAL PHARMACEUTICAL DRUG DELIVERY FOR DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
12. GLOBAL PHARMACEUTICAL DRUG DELIVERY FOR NERVOUS SYSTEM DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
13. GLOBAL PHARMACEUTICAL DRUG DELIVERY FOR RESPIRATORY DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
14. GLOBAL PHARMACEUTICAL DRUG DELIVERY FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
15. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
16. GLOBAL PHARMACEUTICAL DRUG DELIVERY IN HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
17. GLOBAL PHARMACEUTICAL DRUG DELIVERY IN ASC MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
18. GLOBAL PHARMACEUTICAL DRUG DELIVERY IN HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
19. GLOBAL PHARMACEUTICAL DRUG DELIVERY IN DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
20. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
21. NORTH AMERICAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
22. NORTH AMERICAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
23. NORTH AMERICAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
24. NORTH AMERICAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
25. EUROPEAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
26. EUROPEAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
27. EUROPEAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
28. EUROPEAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
29. ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
30. ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
31. ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
32. ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
33. REST OF THE WORLD PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
34. REST OF THE WORLD PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
35. REST OF THE WORLD PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
1. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SHARE BY ROUTE OF ADMINISTRATION, 2018 VS 2025 (%)
2. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
3. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SHARE BY END-USER, 2018 VS 2025 (%)
4. GLOBAL PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
5. US PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
6. CANADA PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
7. UK PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
8. FRANCE PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
9. GERMANY PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
10. ITALY PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
11. SPAIN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
12. ROE PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
13. INDIA PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
14. CHINA PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
15. JAPAN PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
16. REST OF ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
17. REST OF THE WORLD PHARMACEUTICAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
